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Abstract 1 
Accumulation of unfolded proteins can disturb the functions of the 2 
endoplasmic reticulum (ER), leading to ER-stress or unfolded protein responses 3 
(UPR). Recent data have shown that activation of UPR can be found in post-mortem 4 
brains of Alzheimer’s disease (AD) patients; and biological markers for activation of 5 
UPR are abundant in neurons with diffuse phosphorylated tau. Although these 6 
observations suggest a linkage between ER-stress and tau pathology, little is known of 7 
their relationship. In this study, we found that high levels of phosphorylated PKR-like 8 
ER-resident kinase (p-PERK) and phosphorylated eukaryotic initiation factor 2 alpha 9 
(p-eIF2 as markers for activation of UPR in the hippocampus of aged P301L 10 
mutant tau transgenic mice. The immunoreactivity of p-PERK was found to co-11 
localize with that of phosphorylated tau. We then hypothesized that phosphorylation 12 
of tau could induce ER-stress and vice versa in promoting AD-like pathogenesis. By 13 
using the protein phosphatase 2A (PP2A) inhibitor okadaic acid (OA) as an inducer 14 
for phosphorylation of tau, we found that primary cultures of rat cortical neurons 15 
treated with OA triggered UPR as indicated by increased levels of p-PERK and p-16 
eIF2 splicing of mRNA for xbp-1 and elevated levels of mRNA for GADD153. On 17 
the other hand, thapsigargin (Tg) as an ER-stress inducer stimulated phosphorylation 18 
of tau at Thr231, Ser262 and Ser396. Tg also induced activation of caspase-3 and 19 
cleavage of tau. These findings suggested that ER-stress and hyperphosphorylation of 20 
tau could be induced by each other to form a vicious cycle to propagate AD-like 21 
neurodegeneration. (Word count: 246) 22 
23 
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INTRODUCTION 1 
 Alzheimer’s disease (AD) is an aging-associated neurodegenerative disease 2 
leading to progressive cognitive impairment and memory loss. Among various 3 
pathological changes in the development of AD, accumulation of senile plaques and 4 
neurofibrillary tangles (NTFs) has long been considered to be two distinct 5 
pathological hallmarks. Senile plaques are extracellular aggregates of -amyloid (A) 6 
protein; NTFs are intracellular filamentous inclusions which mainly consist of 7 
abnormally hyperphosphorylated and aggregated tau protein [1]. Both A and tau are 8 
found in misfolded and aggregated forms in AD, suggesting that impairment of 9 
protein folding machinery is involved in the pathogenesis of AD. 10 
 11 
 In the eukaryotic cell, the endoplasmic reticulum (ER) is responsible for 12 
protein synthesis, correction of protein folding, post-translational modification and 13 
transport. In physiological circumstances, there is strict control of protein folding 14 
machinery, with misfolded proteins either retained in the ER for further correction of 15 
their folding or subjected to degradation [2]. Disturbance in the ER integrity or 16 
folding machinery by accumulation of misfolded proteins or changes of calcium 17 
homeostasis in the ER can trigger ER-stress responses, or the unfolded protein 18 
response (UPR) [3]. Shortly after perturbation of ER homeostasis, UPR can serve as 19 
an adaptation process to prevent further disturbance of cellular functions. Three ER-20 
stress signaling pathways, including activation transcription factor 6 (ATF6), double-21 
stranded RNA-dependent protein kinase (PKR)-like ER-resident kinase (PERK) and 22 
inositol requiring 1 (IRE1), are activated. These signaling cascades lead to increase 23 
production of ER-resident chaperones and foldases such as BiP/GRP78 to enhance 24 
efficiency of protein folding; the activation of eukaryotic initiation factor 2 alpha 25 
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(eIF2) to shut down global protein translation for newly transcribed genes [4]; and 1 
the upregulation of ER-associated degradation to promote clearance of misfolded 2 
proteins [5]. Hence, UPR is considered to be initially protective. 3 
  4 
 However, sustained activation of the UPR can induce apoptotic responses that 5 
would finally cause cell death [6]. Although the involvement of ER-stress in 6 
neurodegenerative diseases such as AD and Parkinson’s disease has been widely 7 
reported [7-9], the mechanisms by which ER-stress participates in neurodegenerative 8 
processes are not fully understood. Many studies reported the direct activation of both 9 
intrinsic and extrinsic apoptotic pathways by ER-stress [10-12]. Apart from apoptosis, 10 
it has also been suggested that ER-stress would alter cellular responses and sensitize 11 
neurons to A toxicity, hence enhancing A-induced neurodegeneration [13]. 12 
 13 
 In postmortem AD brains, the levels of UPR markers such as BiP/GRP78 and 14 
p-PERK were found to be increased in the cortex and hippocampus [14,15], 15 
suggesting the involvement of ER-stress in AD pathogenesis. It is important to 16 
understand the role of ER-stress in the pathogenesis of AD and the related signaling 17 
pathways for the development of promising therapeutic interventions [16]. In familial 18 
AD (FAD), mutation of presenilin-1 (PS1) can alter signaling of UPR sensitizing 19 
neurons to be more vulnerable to stress. Mutant PS1 might increase the vulnerability 20 
of neurons to ER-Golgi toxin-induced apoptosis [17]; mutation of PS1 can also 21 
deregulate the expression of PERK, IRE1 and ATF-6 under ER-stress [8]. However, 22 
most AD cases are sporadic and lack PS1 mutations. As accumulation of aggregated 23 
A and hyperphosphorylated tau have been considered to be the significant features in 24 
AD, it is reasonable to speculate that A or tau are responsible for the induction of 25 
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ER-stress observed in AD. Previously, our laboratory had reported that extracellular 1 
accumulation of A peptide in both fibrillar and oligomeric forms was not able to 2 
induce the UPR in primary cultures of cortical or hippocampal neurons [18,19]. In 3 
combination with the results showing that UPR was activated in pre-tangle neurons in 4 
AD brain [14], we speculated that hyperphosphorylated tau, instead of A peptide, 5 
might play an important role in inducting ER-stress in AD. In the last two years, 6 
several studies had been conducted to investigate the effects of ER-stress on tau 7 
protein. The results, however, were controversial [14,20], and it is necessary to further 8 
clarify the relationship between ER-stress and tau. 9 
 10 
In this study, we hypothesized that hyperphosphorylation of tau can induce 11 
ER-stress and vice versa in promoting pathogenesis of AD. Both transgenic mouse 12 
models and in vitro models were used to investigate the relationship between ER-13 
stress and tau pathology. We found increased levels of p-PERK and p-eIF2 in the 14 
hippocampus of aged P301L mutant tau transgenic mice. Immunoreactivity of these 15 
two phospho-proteins co-localized with hyperphosphorylated tau. In primary cultures 16 
of cortical neurons, we observed that hyperphosphorylation of tau was induced by 17 
okadaic acid. Furthermore, we found that thapsigargin-induced ER-stress could 18 
trigger hyperphosphorylation as well as tau cleavage of tau. Our results suggested that 19 
hyperphosphorylation of tau and ER-stress can promote the initiation of each other 20 
and form a vicious cycle contributing to AD-like pathology.  21 
22 
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MATERIAL AND METHODS 1 
Materials and chemicals 2 
Materials for cell culture, including minimum essential medium (MEM), 3 
NeurobasalTM medium, B-27 supplement, penicillin and streptomycin, were 4 
purchased from Gibco-BRL (Burlington, Ont., Canada). Other chemicals were 5 
obtained from the following companies: Thapsigargin (Tg) and okadaic acid (OA) 6 
were from Calbiochem, Inc. (La Jolla, CA, USA). 4-Phenyl butyric acid (4-PBA), 7 
protease inhibitor cocktail, phosphatase inhibitor cocktail, 4’6-Diamidino-2-8 
phenylindole (DAPI), mouse monoclonal anti-β-actin antibody and mouse 9 
monoclonal anti--tubulin antibody were obtained from Sigma-Aldrich, Inc. (St. 10 
Louis, MO, USA). Mouse monoclonal antibody against cleaved-Tau (Asp421) was 11 
purchased from Upstate (Lake Placid, New York, USA). Rabbit polyclonal antibody 12 
against phosphorylated eIF2 (Ser51), tau pS396 against tau phosphorylated at 13 
Ser396, tau pT231 against tau phosphorylated at Thr231, tau pS262 against tau 14 
phosphorylated at Ser262 and mouse polyclonal antibody tau-1 against non-15 
phosphorylated tau at Ser198/199/202 were purchased from BioSource International 16 
(Hopkinton, MA, USA). Horseradish peroxidase-conjugated goat anti-rabbit and goat 17 
anti-mouse antibodies were from DAKO (Glostrup, Denmark). Rabbit monoclonal 18 
antibody against phosphorylated PERK (Thr980), rabbit monoclonal antibody against 19 
total PERK, rabbit polyclonal antibody against anti-BiP, total eIF2, phosphorylated-20 
GSK3 (Ser9) and cleaved-caspase-3 were purchased from Cell Signaling 21 
Technology (Beverly, MA, USA). Mouse polyclonal antibody anti-GSK3 (pY216) 22 
to detect phosphorylated GSK3 at Tyr216, antibody Tau-5 to detect total tau and 23 
antibody against total GSK3 were from BD Transduction Laboratories (CA, USA). 24 
Polyvinylidene difluoride (PVDF) membrane was from Bio-Rad (Richmond, CA, 25 
Ho et al., 2011 
 
8
USA). Biomax X-ray film was from GE Healthcare (New York, USA). Enhanced 1 
chemiluminescence (ECL) detection kit was from Amersham (Buckinghamshire, UK). 2 
Anti-mouse or anti-rabbit Alexa fluor-488 or -568, Anti-Fade Gold mounting medium 3 
and Fluo-4AM were from Molecular Probes, Invitrogen. Anti-PHF-tau antibody 4 
clones AT180 against phosphorylated tau at Thr231 and Ser235 was from Thermo 5 
Scientific (Rockford, USA). Rabbit polyclonal antibody against human-tau (K9JA/ 6 
pan-tau, recognize the total tau at C-terminal part, amino acids 243–441) was from 7 
DAKO (USA). 8 
 9 
Primary cultures of hippocampal and cortical neurons and drug treatment 10 
 Primary cultures of rat hippocampal and cortical neurons were prepared from 11 
embryonic day 17 Sprague-Dawley rat embryos (The Laboratory Animal Unit, The 12 
University of Hong Kong) via the method described previously [21,22]. Briefly, 13 
cerebral cortices or hippocampus were dissected in 1X phosphate-buffered saline 14 
(PBS) supplemented with glucose (18 mM). Neurons were then mechanically 15 
dissociated. Hippocampal neurons were seeded onto glass coverslips pre-coated with 16 
poly-L-lysine (25 μg/ml) at a density of 0.7 × 105 cells/coverslip. They were cultured 17 
with NeurobasalTM medium containing 2% B-27, L-glutamine (2 mM), penicillin (50 18 
U/ml) and streptomycin (50 μg/ml). Cortical neurons were seeded onto 6-well plates 19 
pre-coated with poly-L-lysine (25 μg/ml) at a density of 1.2 × 106 cells/well. They 20 
were cultured with minimum essential medium (MEM) supplemented with 5% heat 21 
inactivated fetal bovine serum, glucose (18 mM), L-glutamine (2 mM), insulin (5 22 
μg/ml), progesterone (0.02 μM), putrescine (100 μM), selenium (30 pM), penicillin 23 
(50 U/ml) and streptomycin (50 μg/ml). All the neurons were maintained at conditions 24 
of 37°C in a humidified 5% CO2 atmosphere. Deoxyfluorouridine (final concentration 25 
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1 M) were added into cultures on DIV 2 to remove glial cells. All experiments were 1 
performed on DIV 7. 2 
 3 
To induce hyperphosphorylation of tau, the protein phosphatase 2A (PP2A) 4 
inhibitor OA prepared as a 0.2 mM stock solution in DMSO was added into cultures 5 
at a final concentration of 50 nM for the indicated duration. For control experiments, 6 
DMSO was added at the final concentration present in the OA-treated cultures 7 
(0.025%).  8 
 9 
To induce ER-stress, Tg prepared as a 10 mM stock solution in DMSO was 10 
added into cultures at final concentrations of 4 or 10 nM for the indicated duration. 11 
For control experiments, DMSO was added at the final concentration present in the 12 
Tg-treated cultures (0.0001%). In some experiments, the chemical chaperone 4-13 
phenyl butyric acid (PBA) 1 mM was added at the same time as Tg. The cultures were 14 
then incubated for 6 h before they were harvested for Western blot analysis. 15 
 16 
Brain samples of transgenic mice expressing P301L human tau 17 
The transgenic mice (JNPL3 mice) expressing human mutant P301L tau 18 
(proline to leucine mutation at amino acid 301 in exon 10) have been described 19 
previously [23]. These TgTauP301L mice develop tau pathologies (tau 20 
hyperphosphorylation and aggregation) starting from age 3-months and increasing in 21 
severity with age [24]. Male wild type and TgTauP301L mice were sacrificed at age 21 22 
months, and the brains were quickly excised and processed according to the following 23 
procedures. For Western blot analysis, brains were micro-dissected for the 24 
hippocampus and snap-frozen immediately in liquid nitrogen and stored at -80°C 25 
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before use. For histological and immunohistochemical analyses, all mouse brains 1 
were fixed with 0.1 M phosphate buffer (pH 7.6) containing 4% paraformaldehyde 2 
and embedded in paraffin. Each group contained at least 4 animals (n=4) for both 3 
immunohistochemical staining and Western blot analysis. In this study, we only focus 4 
on the hippocampus because it is the region mostly relevant to the development of AD, 5 
especially in the early stage. Since we did not keep the mice, other brain regions had 6 
been used by other investigators.  7 
 8 
Immunohistochemical staining 9 
 For immunohistochemical analysis, consecutive 4-m-thick coronal mouse 10 
brain sections were cut. After dewaxing and rehydration, the sections were treated 11 
with 0.01 M citrate buffer (pH 6.0) with 0.1% Tween-20 at 90°C for 15 min for 12 
antigen retrieval. The sections were then blocked with 10% normal goat serum in PBS 13 
for 1 h. Sections were co-incubated with primary antibody AT180 (1:200) and 14 
phosphorylated-PERK (1:200) at 4°C overnight. After washing with PBS, the sections 15 
were stained with secondary antibody, Alexa fluor-488 or -568 for 2 h and finally 16 
stained with DAPI for revealing the nuclei. Sections were then mounted with Anti-17 
Fade Gold mounting medium. The sections were examined with a BioRad Radiance 18 
2100 confocal microscopic system. 19 
 20 
Western blot analysis 21 
Total lysate was collected from cell culture or mouse brain samples as 22 
described elsewhere [25]. In brief, cultured neurons or brain samples were lysed in 23 
ice-cold lysis buffer (10 mM Tris-HCl (pH 7.4), 1 mM NaCl, 20 mM Na4P2O7, 2 mM 24 
Na3VO4, 1% Triton-X-100, 10% glycerol, 0.5% deoxycholate, 0.1% SDS, 1 mM 25 
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phenylmethylsulfonyl fluoride, protease inhibitor cocktail and phosphatase inhibitor 1 
cocktail). After homogenization and centrifugation, the supernatant was collected. 2 
The sample were subjected to SDS 10% or 12.5% polyacrylamide gels electrophoresis 3 
and transferred to PVDF membranes. Membranes were blocked with 5% w/v non-fat 4 
milk in TBST (TBS containing 0.1% Tween-20) for 1 h to prevent non-specific 5 
binding. Primary antibodies were diluted in TBST and incubated with the membrane 6 
as described follow: cleaved caspase-3 (1:2000), cleaved-tau (Asp421) (1:1000), tau 7 
pS396 (1:4000), tau pT231 (1:4000), tau pS262 (1:2000), tau-1 (1:30,000), pan-tau 8 
(1:4000), phosphorylated PERK (1:1000), total PERK (1:1000), phosphorylated 9 
eIF2 (1:1000), total eIF2 (1:2000), BiP (1:1000), p35/p25 (1:2000), CDK5 10 
(1:2000), p-GSK3 (Ser9) (1:4000), p-GSK3 (pY216) (1:6000). After washing, the 11 
membranes were incubated with horseradish peroxidase-conjugated secondary 12 
antibodies (1:2000) for 1 h and subsequently developed by using the ECL or ECL-13 
plus Western blotting detection kit. The membranes were then stripped with stripping 14 
buffer (50 mM glycine, 2% SDS, pH 2.0) and re-probed with monoclonal anti-β-actin 15 
antibody (1:10,000, 1 h) and goat anti-mouse HRP secondary antibody. Optical 16 
density of the blots was measured with Image J software (National Institutes of Health, 17 
USA). 18 
 19 
Analysis of splicing in x-box binding protein (xbp-1) mRNA 20 
Splicing in xbp-1 mRNA was investigated by RT-PCR and PstI restriction 21 
enzyme digestion as in our previous studies [18,19]. After treatment with OA, 22 
extraction of RNA and reverse transcription were carried out. cDNA of Xbp-1 was 23 
amplified using PCR (Invitrogen) with xbp-1 specific primers (Table 1) in a 24 
RoboCycler 96 (Stratagene). The PCR cycles consisted of denaturation at 94oC for 1 25 
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min, annealing at 62oC for 1 min and extension at 72oC for 1 min, for 33 cycles. PstI 1 
(New England Biolabs) restriction digestion of the 600 bp PCR products was done at 2 
37oC for 16 h. The restriction fragments were separated on a 1% (w/v) agarose gel 3 
with ethidium bromide and visualized under UV illumination. 4 
 5 
Reverse Transcription (RT)-PCR 6 
After exposure to OA [50 nM] for different times, total RNA from neurons 7 
was extracted with NucleoSpin® RNA II (Macherey-Nagel, Germany). Total RNA 8 
yields were measured by A260/280 using GenQuant II (Pharmacia Biotech). 1 μg 9 
RNA was reverse-transcribed into cDNA with Superscript
TM 
III first strand synthesis 10 
system (Invitrogen) for RT-PCR. PCR was done in a RoboCycler 96 (Stratagene) 11 
with Taq polymerase (Invitrogen). Target genes for amplification and their primer sets 12 
and thermal conditions are listed in Table 1. 13 
 14 
Measurement of intracellular free calcium concentration ([Ca2+]i) 15 
Cultured cortical neurons were incubated with Fluo-4AM [1 M] in cell 16 
culture medium as indicated above for 30 min at 37°C. After incubation, the loading 17 
medium was removed, and cells were washed with 1X HBSS and maintained in 0.5 18 
ml of the same solution in dark. The fluorescence signals were recorded at 488 nm 19 
(excitation wavelength) and 538 nm (emission wavelength) with a Bio-Rad Radian 20 
2100 confocal microscope system. Upon measurement, the first 120 s were recorded 21 
to serve as the baseline of [Ca2+]i before any drug application. At 120 s, Tg was added 22 
into the culture dish to a final concentration of 10 nM or 20 M. The [Ca2+]i was 23 
recorded for another 400 s. At least 4 independent experiments were performed, and 24 
the readings of 9 neurons were recorded from each individual experiment. Data were 25 
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represented as fold of control [fold of control was calculated as follows = reading at 1 
particular time point/ mean of reading of baseline]. 2 
 3 
Statistical analysis 4 
 Data were expressed as mean ± standard error (SE) from at least 3 5 
independent experiments. The significance of the differences among different groups 6 
was determined by unpaired t-test or one-way ANOVA, followed by Student 7 
Newman-Keuls as post-hoc test. P < 0.05 was considered to be statistically significant. 8 
9 
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Results 1 
Increased levels of UPR markers were observed in the hippocampus of aged P301L 2 
tau transgenic mice 3 
 In postmortem AD brains, immunoreactivity of p-PERK was found to be 4 
increased and associated with phosphorylated tau [14]. To explore the relationship 5 
between ER-stress and tau pathology, we examined the levels of p-eIF2 and p-6 
PERK in 21-month-old TgTauP301L mice. Levels of p-eIF2 in hippocampus of 7 
TgTauP301L mice were 3.2 ± 0.4 fold those of age-matched controls (Fig. 1A). 8 
Activation (phosphorylation) of eIF2 can lead to inhibition of protein translation, 9 
and eIF2can be phosphorylated by up-stream kinases such as double-stranded 10 
RNA-dependent protein kinase (PKR), PERK, amino acids-regulated eIF2 kinase 11 
(GCN2) or heme-regulated eIF2 kinase (HRI) [26]. Among these kinases, the role of 12 
PERK during ER-stress has been well-reported; therefore, we further examined the 13 
immunoreactivity of p-PERK in brain sections of these transgenic mice. We found 14 
that the immunoreactivity of p-PERK was markedly increased in the hippocampus of 15 
TgTauP301L mice compared to age-matched controls. Furthermore, the elevated 16 
immunoreactivities of p-PERK were found to be co-localized with AT180 17 
immunoreactivity, which detects tau phosphorylated at Thr231 and Ser235 (Fig. 1B). 18 
Thus, ER-stress was increased in aged TgTauP301L mice. 19 
 20 
Induction of tau hyperphosphorylation led to ER-stress in primary cultures of cortical 21 
neurons 22 
 In the previous section, we had demonstrated that aged TgTauP301L mice had 23 
increased levels of p-PERK, which was co-localized with AT180 staining. Our results 24 
suggested that there might be a direct linkage between phosphorylation of tau and ER-25 
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stress. We then asked whether the UPR was induced by hyperphosphorylation of tau. 1 
OA is a well-reported inducer for hyperphosphorylation of tau; it acts by inhibiting 2 
protein phosphatase 2A (PP2A) that is responsible for dephosphorylation of tau 3 
[27,28]. OA was applied to primary cultures of cortical neurons to induce 4 
hyperphosphorylation of tau. As shown in Fig. 2A-E, 50 nM OA induced the 5 
hyperphosphorylaton of tau on Thr231, Ser396 and Ser198/199/202 at different time 6 
points. Except for phosphorylated tau at Ser396, which decreased after 16 h, the other 7 
phosphorylation sites of tau showed persistent increases in their immunoreactivity. It 8 
had been reported that changes in some tau epitopes induced by OA were more 9 
persistent than others; hence our results were consistent with previous findings [29]. 10 
The level of total tau (as detected by the Tau-5 and K9JA antibodies) was decreased 11 
in neurons exposed to OA (Fig. 2A and Supplementary Fig. 3A), which has been 12 
previously reported by another group [30]. It has been speculated that the reduction in 13 
total tau indicates either an enhanced clearance of aggregated tau (due to 14 
hyperphosphorylation) or an ineffectiveness of detection for aggregated tau by 15 
Western blot analysis. Nevertheless, OA clearly induced hyperphosphorylation of tau. 16 
To further confirm our observation, we performed immunocytochemical staining on 17 
primary cultures of hippocampal neurons; and we found that OA could also induce 18 
tau hyperphosphorylation in these cells (Supplementary Fig.1). Since we observed 19 
similar phenomenon between the two cell types, and there were limited availability of 20 
primary hippocampal neurons, we used cortical neurons for most of our experiments. 21 
 We then detected the presence of ER-stress by OA. We found that 22 
immunoreactivity of p-PERK significantly increased from 6 to 24 h while that of p-23 
eIF2 exhibited a tendency toward an increase at all time-points (though statistically 24 
significance was only detected at 24 h) (Fig. 2F, G, I). The level of BiP was 25 
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unchanged at all tested time-points. To further confirm the presence of UPR in 1 
neurons after treatment of OA, we detected splicing of mRNA for xbp1 and the 2 
mRNA level of GADD153 (growth arrest-and DNA damage-inducible gene 153). 3 
UPR activates IRE1 to function as an endoribonuclease to splice mRNA for xbp-1 by 4 
cutting off a 26-nucleotide intron [31]. This would prevent the digestion of mRNA for 5 
xbp-1 (~600bp) by Pst1 as the Pst1 restriction enzyme cutting site is within the 6 
excised 26-nucleotide sequence. Fig. 2J shows that it was about 600 bp of mRNA for 7 
xbp-1 before Pst1 digestion in all treatment groups. After Pst1 digestion (Fig. 2K), 8 
fragments of about 300 bp were only found in controls. In neurons exposed to OA for 9 
16 or 24 h or to DTT [1mM] for 24 h (a positive control), the digestion of xbp-1 by 10 
Pst1 to yield a 300 bp fragment was attenuated, indicating the splicing of mRNA for 11 
xbp-1. Our results suggested that OA induced UPR and activation of IRE1. 12 
GADD153 is a highly inducible gene responsive to ER-stress; its expression increases 13 
during UPR [32]. As shown in Fig. 2L, the level of mRNA for GADD153 14 
significantly increased after exposure of neurons to OA for 16 and 24 h. Taken 15 
together, our data showed that OA-induced hyperphosphorylation of tau could trigger 16 
UPR. 17 
 18 
Induction of ER-stress by thapsigargin led to increased phosphorylation of tau in 19 
primary cultures of cortical neurons 20 
Our in vivo and in vitro data suggested that hyperphosphorylation of tau could 21 
induce ER-stress. It has well been reported that prolonged ER-stress can lead to 22 
apoptosis. Besides inducing neuronal cell death as late and final events, ER-stress 23 
may also induce other pathological changes which are involved in the 24 
neurodegenerative process of AD. We, therefore, examined the effects of thapsigargin 25 
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(Tg) as a typical ER-stress inducer on an in vitro model of primary cultures of cortical 1 
neurons. Tg is a specific inhibitor of intracellular Ca2+-transport ATPases. It blocks 2 
the activity of the enzyme to induce perturbation of intracellular calcium homeostasis, 3 
resulting in ER-stress. As shown in Fig. 3A-D, 10 nM Tg induced an elevation of 4 
immunoreactivities of UPR markers including p-PERK and BiP in a dose-dependent 5 
manner. We then detected the levels of phosphorylated tau. The band intensity of 6 
phosphorylated tau at Thr231, Ser262 and Ser396 was found to increase at 6 and 12 h 7 
time points (Fig. 3E-H). These elevated immunoreactivities of phosphorylated tau 8 
were then reduced at 18 h and became similar to levels of the controls. The 9 
immunoreactivity of phosphorylated tau (Thr231 and Ser396) continued to decrease 10 
and became markedly lower than the controls at 24 h (Fig. 3F and H). The 11 
immunoreactivity of Tau-5 and K9JA (both detected total tau level) among all the 12 
treatment groups was similar without significant change, 13 
 14 
Truncation of tau was induced by ER-stress 15 
 It has been reported that Tg-induced ER-stress can lead to activation of 16 
caspase-3 and apoptosis [33]. Tau is a substrate of caspase-3, and its cleaved form is 17 
pro-apoptotic [34] and is more prone to form aggregates [35]. We therefore examined 18 
the levels of caspase-3 and cleaved tau in our Tg-treated cortical neurons. We found 19 
that the immunoreactivity of cleaved caspase-3 showed a trend toward increase after 20 
12 h exposure to 10 nM Tg. After 18 or 24 h incubation, the immunoreactivity of 21 
cleaved caspase-3 significantly increased to nearly 3-fold of the control. The increase 22 
also showed a dose-dependent pattern. At the same time, the immunoreactivity of 23 
cleaved-tau at Asp421 was also elevated in a pattern similar to that of caspase-3 (Fig. 24 
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4). At 18 h, the immunoreactivity of cleaved-tau reached the highest levels and was 1 
more than 7-fold greater than the control (Fig. 4B). 2 
 3 
Induction of tau phosphorylation by Tg [10 nM] was due to the accumulation of 4 
misfolded/unfolded protein 5 
To confirm whether Tg-induced hyperphosphorylation of tau was a result of 6 
UPR, we co-treated cortical neurons with Tg and 4-phenyl butyric acid (4-PBA), a 7 
chemical chaperone which can enhance the adaptive capacity of the ER [36]. As 8 
shown in Fig. 5A-D, 1 mM 4-PBA significantly reduced the immunoreactivity of 9 
phosphorylated tau induced by Tg. There was little effect of 4-PBA itself on 10 
immunoreactivities of phosphorylated tau at Thr231 and Ser 262, but 4-PBA did 11 
increase the immunoreactivity of phosphorylated tau at Ser396. Our results confirmed 12 
the role of ER-stress in Tg-induced tau phosphorylation. 13 
 14 
Exposure of cortical neurons to Tg [10 nM] did not induce acute increase of [Ca2+]i  15 
Tg can disturb intracellular calcium homeostasis and cause a transient increase 16 
in [Ca2+]i [37]. Previous study has shown that a transient increase in [Ca2+]i can result 17 
in prolonged phosphorylation of some tau epitopes [38]. To investigate the 18 
downstream causative factors that mediated phosphorylation of tau in our Tg-treated 19 
cultures, we measured the levels of [Ca2+]i. Our data showed that 10 nM Tg did not 20 
trigger an acute and transient increase in [Ca2+]i. There was a mild increase in [Ca2+]i 21 
only for 1.06 ± 0.02 fold of control. There were only gradual changes in [Ca2+]i 22 
induced by 10 nM Tg. As a positive control, we also treated cortical neurons with 20 23 
M Tg, and we found that this concentration of Tg could induce a 1.43 ± 0.08 fold 24 
increase in [Ca2+]i. As shown in Fig. 6, 20 M Tg induced a typical calcium influx 25 
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pattern, in which [Ca2+]i increased immediately after loading of Tg, peaked at about 1 
240 s,  then decreased gradually.  2 
 3 
Tg did not induce significant change in the level of p-GSK3  4 
 To investigate possible upstream kinases affected by ER-stress and tau 5 
phosphorylation, we detected the levels of p-GSK3, by Western-blot analysis (Fig. 6 
7A). GSK-3β can be activated by dephosphorylation at Ser 9 or phosphorylation at 7 
Tyr 216. We found that the immunoreactivity of p-GSK3(Ser9) showed a trend 8 
toward increase at 6 h and remained the same as the controls at other detected time 9 
points (Fig. 7B). The immunoreactivity of p-GSK3(pY216) remained the same as 10 
that of the controls at all detected time points (Fig. 7C). There was no significant 11 
change in the protein levels of total GSK3 (data not shown).  12 
13 
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Discussion 1 
 ER-stress can trigger UPR, which is an adaptive response to cope with the 2 
accumulation of misfolded proteins. It is believed that ER-stress is linked to a number 3 
of neurodegenerative diseases including AD [3]. In postmortem AD brain, activation 4 
of the UPR was found in neurons with diffuse phosphorylated tau [14,15]; yet the 5 
temporal sequence of the events is not clear. Our study aims to investigate the 6 
causative relationship between ER-stress and phosphorylation of tau. By using three 7 
models, both in vivo and in vitro, we provide evidence that ER-stress and tau 8 
phosphorylation are closely linked.  9 
 10 
 Our initial hypothesis is to prove that abnormal tau can lead to ER-stress and 11 
activation of UPR. To study the chronic effects of tau pathology on ER-stress, 12 
transgenic mice which display phosphorylated and aggregated tau would be an 13 
appropriate experimental model as they can mimic the chronic disease development 14 
process. The first model we used was therefore aged TgTauP301L transgenic mice. 15 
These mice expressed the P301L mutant version of the longest form of human tau 16 
(4R0N), which can cause frontotemporal lobe dementia with parkinsonism linked to 17 
chromosome 17 (FTDP-17). They developed pre-tangles and NFTs with increasing 18 
age [23]. Tau pathology can be observed in different regions of the P301L mice 19 
including the cortex, hippocampus, midbrain and cerebellum. Since we only focused 20 
on the hippocampus in this study, we are not sure if similar phenomenon on ER stress 21 
can be observed in other regions. The change of cognitive functions in P301L mice 22 
has been studied by other groups. Although there was a report showing normal 23 
cognitive function of these mice [39], another study found that these mice had poorer 24 
cognitive performance, which was associated with increased number of 25 
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phosphorylated tau containing neurons in cerebral cortex and hippocampus [40]. 1 
Another group also reported that the P301L mice showed decline in cognitive 2 
functions evaluated by Morris-water maze test [41]. Hence, TgTauP301L transgenic 3 
mice can be an appropriate animal model for studying tau pathology related to ER-4 
stress. In view of all these published behavioral reports of cognitive functions of this 5 
line of mice, our study mainly focused on the pathological changes in these mice 6 
rather than the behavioral functions. We therefore did not perform cognitive function 7 
tests. Our data showed that the levels of p-PERK were elevated in the hippocampus of 8 
aged TgTauP301L mice, and the staining was co-localized with phosphorylated tau. The 9 
levels of p-eIF2 were also increased in the hippocampus of these transgenic mice. 10 
Our data have proved that ER-stress and UPR occur in aged TgTauP301L mice; and 11 
hence ER-stress and tau pathology might have a casual relationship. In fact, a 12 
previous report showed that the amount of tau protein was preferentially increased in 13 
the membrane of the rough ER in motor neurons of TgTauP301L mice; and 14 
hyperphosphorylated tau was associated with the ER membrane in AD brains [42]. 15 
These findings further support the notion that abnormal tau would affect ER function 16 
in the neurodegenerative process. Interestingly, another research group has reported 17 
recently that they could not find any evidence of ER-stress or UPR activation in 18 
another mutant tau transgenic mice model [20]. In that study, transgenic mice 19 
expressing the P301S mutant version of human tau (PS19 transgenic mice) were used. 20 
These PS19 transgenic mice gradually developed synaptic loss, neuronal loss and 21 
NFTs with increasing age [43]. The reason for the opposite results observed in these 22 
two transgenic models is unclear. One may question that the elevation of ER-stress 23 
markers in our model may be due to the specific mutant i.e. P301L. Since we do not 24 
have the htau mice which overexpress human wild-type tau, we cannot examine the 25 
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levels of ER-stress in these animals to exclude the possibility. In this study, the use of 1 
TgTauP301L mice only serve as an model to show that tau phosphorylation is correlated 2 
to ER-stress, and we are not intend to use it as an experimental model of AD. 3 
 4 
 With the results in transgenic animals, it is better to further study the 5 
mechanisms in vitro. We further prove that phosphorylation of tau can lead to ER-6 
stress in an in vitro model. Previous findings reported by Kim et al. have shown that 7 
OA induced the phosphorylation of eIF2 and hence the translocation of activating 8 
transcription factor (ATF4) and induction of apoptosis [44]. Our present study further 9 
proved the involvement of ER-stress in OA-induced phosphorylation of tau. Our 10 
preliminary data showed that phosphorylation of tau occurs as early as 1 h after OA 11 
treatment, while the levels of p-eIF2 also increased as early as 1 h. It is known that 12 
eIF2 can be phosphorylated under many situations, and its phosphorylation alone is 13 
insufficient to prove the presence of ER-stress. Here we reported that, after OA 14 
treatment, elevation of the levels of p-PERK was observed only after 6 h; splicing of 15 
mRNA for xbp-1 and increased expression of mRNA for GADD153 were observed 16 
only at late time points (16 and 24 h). These findings clearly demonstrated activation 17 
of the PERK and IRE1 pathways in the UPR; and more importantly, the occurrence of 18 
the UPR follows the phosphorylation of tau, suggesting a causal relationship between 19 
the two factors. In the later time points i.e. 16 h and 24 h, the levels of phosphorylated 20 
tau at Ser 396 decreased (Fig. 2A). Although we did not study the apoptotic signal or 21 
apoptotic state in OA-treated neurons as it is not our aim of study, previous report 22 
documented that treatment with OA leads to apoptosis in late time points [45]. This 23 
decrease in tau phosphorylation may be explained by the entrance of the early phase 24 
of apoptosis [46]. It was shown that when neurons were exposed to stress factors such 25 
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as staurosporine, tau was first hyperphosphorylated transiently and then undergone 1 
dephosphorylation and cleavage, followed by apoptosis [47]. We speculate that under 2 
OA-treatment, tau may also be dephosphorylated when neurons undergo apoptosis. 3 
 4 
 While phosphorylation of tau can induce UPR, induction of ER-stress has 5 
been shown to induce phosphorylation of tau. Tg was used to induce ER-stress in our 6 
study. In many studies [48,49], high concentrations of Tg at micromolar levels were 7 
used to induce ER-stress and apoptosis. Since we aimed to examine the events that 8 
occur before the induction of apoptosis, we chose a very low dose of Tg (10 nM) to 9 
induce ER-stress. It has been shown that treatment of primary cultures of cortical 10 
neurons with Tg [10 nM] for 24 h did not affect cell viability, and significant cell 11 
death was observed at 48 h [48]. We demonstrated here that this low concentration of 12 
Tg could induce the UPR as early as 6 h; and at the same time, there was a transient 13 
increase in the phosphorylation of tau. Interestingly, when we investigated the kinases 14 
that may be responsible for Tg-induced tau phosphorylation, we found that GSK3 15 
was unlikely to be involved. The levels of p-GSK-3 (Ser9), which is the inactivated 16 
form, were even increased after Tg treatment. This contradicts to a recent report 17 
suggesting that Tg-induced phosphorylation of tau could be attenuated by inhibiting 18 
activity of GSK3 [50]. Since we used primary cultures of cortical neurons as our 19 
model system, while they used a neuronal cell line and animals in their study, it is 20 
difficult to have a direct comparison between the results. Another possibility for 21 
causing the discrepancy would be the dosage of Tg in the experiments. The 22 
concentration of Tg in our study was very low. As shown in Fig. 6, 10 nM Tg did not 23 
induce even a sharp and transient increase in [Ca2+]i, yet this dosage of Tg was 24 
sufficient to induce ER-stress as shown in Fig. 3. It has been shown that Tg at even 25 
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subnanomolar concentration is effective at inhibiting Ca2+-ATPase [51]. Our data 1 
suggested that tau was very sensitive to environmental stress, and post-translational 2 
modification of tau can be altered by a slight change in intracellular homeostasis. In 3 
Tg-treated neurons, apart from phosphorylation, truncation of tau was also observed 4 
together with activation of caspase-3 at late time points (Fig. 4). Caspase-cleaved tau 5 
in immortalized cortical neurons was found to increase neuronal susceptibility to ER-6 
stress [52]. Hence, it is possible that the cleaved tau generated after treatment of Tg 7 
can further promote UPR leading to neurodegeneration. It is worth to note that in the 8 
late time points (18 and 24 h), the levels of UPR markers continued to increase while 9 
that of phosphorylated-tau decreased. Under the exposure of Tg, it is not surprised 10 
that ER-stress response would continue in the later time points. The prolonged ER-11 
stress displayed activated caspase-3, the observed tau dephosphorylation and cleavage 12 
may therefore represent the entrance of the execution phase of apoptosis [53]. Since 13 
the phosphorylation of tau can be affected by multiple factors during prolonged stress, 14 
this makes it more difficult to observe the causal relation between ER stress and tau 15 
hyperphosphorylation. Nevertheless, we showed that the chemical chaperone 4-PBA 16 
reduced the levels of phosphorylated-tau in Tg-treated neurons in early time point (6 17 
h). This gives evidence that the level of ER stress is correlated to the changes of 18 
phoshorylated tau. 19 
 While GSK3 is unlikely to be involved in Tg-induced phosphorylation of tau 20 
in our system, we also detected other possible candidates involved in this process. We 21 
found that there were no changes in the levels of p-PP2A (Tyr 307) (data not shown); 22 
but there were dose-dependent decreases in levels of p35, suggesting the possible 23 
involvement of CDK5 (data not shown). Since we did not find a clear increased level 24 
of p25, which is a critical factor for activation of CDK5, the role of CDK5 in Tg-25 
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induced tau pathology will be further investigated. Previous findings suggested that 1 
dysregulation of CDK5 is involved in ER-stress mediated apoptosis [54]. 2 
Nevertheless, detailed mechanistic linkage between ER-stress and phosphorylation of 3 
tau in relation to CDK5 will be further examined. 4 
 5 
 Our findings provide evidence showing that ER-stress and phosphorylation of 6 
tau can induce each other. We propose that ER-stress can play an important role in 7 
AD-like pathogenesis since ER-stress can induce phosphorylation of tau and form a 8 
vicious cycle. This close relationship between ER-stress and tau pathology might be 9 
one of the common pathways to explain the multi-factorial nature of AD. Many risk 10 
factors for AD are found to be associated with ER-stress. For example, prolonged 11 
light illumination of mice to deprive them of sleep has been shown to induce AD-like 12 
pathology and ER-stress [55]; hyperhomocysteinemia and stroke can induce ER-stress 13 
[13,56,57]. Abnormal phosphorylation of tau is always found in these situations 14 
[21,55,58,59]. Given that the consequence of ER-stress responses will be translated 15 
into hyperphosphorylation of tau protein, and ER-stress is very sensitive to 16 
environmental changes (even without perturbation of ER calcium, as demonstrated in 17 
our study), it is therefore understandable that phosphorylation of tau was observed in 18 
different pathological conditions. Understanding the role of ER-stress and its 19 
relationship with tau protein would certainly aid the development of promising 20 
therapeutic interventions for AD. 21 
22 
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Figure legends 1 
Fig. 1 Increased levels of markers for UPR and hyperphosphorylation of tau were 2 
observed in the hippocampus of aged TgTauP301L mice. (A) Western blots show the 3 
levels of p-eIF2 and total eIF2 in the hippocampi of 21-month-old TgTauP301L mice 4 
and age-matched wild type mice (upper panel). Quantitative analysis of the 5 
immunoreactivity of p-eIF2/ total eIF2 was performed by Image J (lower panel). 6 
Data represent mean ± SE from at least 3 independent experiments. Statistical 7 
analysis was performed by unpaired t-test. *p<0.05 compared to WT mice. (B) 8 
AT180 and p-PERK staining of the hippocampi of 21-month-old TgTauP301L mice and 9 
age-matched wild type mice. CA3 region is shown in the photos (40X). There was 10 
little staining of AT180 in WT mice, but AT180 immunoreactivity increased 11 
markedly in the TgTauP301L mice and was colocalized with p-PERK immunoreactivity. 12 
 13 
Fig. 2 OA-induced hyperphosphorylation of tau led to ER-stress in primary cultures 14 
of cortical neurons. Neurons were exposed to OA [50 nM] for 6, 16 or 24 h. (A to E) 15 
The levels of total tau and p-Tau at Thr231, Ser262, and Ser198/199/202 were 16 
detected by Western blot analysis. (F to I) The levels of p-PERK, total PERK, p-17 
eIF2 and total eIF2 were detected by Western blot analysis. β-Actin was used as 18 
internal control. Quantitative analysis of the immunoreactivity of the detected proteins 19 
was performed by Image J. Data represent mean ± SE from at least 3 independent 20 
experiments. Statistical analysis was performed by unpaired t-test. (J) RT-PCR was 21 
performed to amplify mRNA for xbp-1, (K) followed by Pst1 restriction enzyme 22 
digestion. DTT [1mM] served as a positive control to induce alternative splicing in 23 
mRNA for xbp-1, as shown by the absence of ~300 bp digestion fragment after Pst1 24 
restriction enzyme digestion. (L) Levels of mRNA for GADD153 were detected by 25 
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PCR. Photos of agarose gel electrophoresis are representatives from three independent 1 
experiments. (M) Quantitative analysis of the mRNA levels for GADD153 was 2 
performed by Image J. Data represent mean ± SE from at least 3 independent 3 
experiments. Statistical analysis was performed by unpaired t-test. *p<0.05 compared 4 
to corresponding control. 5 
 6 
Fig. 3 Tg induced UPR and phosphorylation of tau in primary cultures of cortical 7 
neurons. Tg [4 or 10 nM] was added to neuronal cultures and incubated for different 8 
durations to induce ER-stress. (A to D) The levels of UPR markers including p-PERK, 9 
BiP/GRP78, and p-eIF2 were detected by Western blot analysis. (E to H) The levels 10 
of total tau and p-tau at Thr231, Ser262 and Ser396 at different time-points were 11 
detected. -Tubulin was used as internal control. Quantitative analysis of the 12 
immunoreactivity was performed by Image J. Data represent mean ± SE from at least 13 
3 independent experiments. Statistical analysis was performed by one-way ANOVA 14 
for multiple comparisons, followed by Student Newman-Keuls as post-hoc test. 15 
*p<0.05 compared to corresponding control. 16 
 17 
Fig. 4 Tg induced activation of caspase-3 and truncation of tau. Tg [4 or 10 nM] was 18 
added into neuronal cultures and incubated for different durations to induce ER-stress. 19 
(A) The levels of cleaved tau and cleaved caspase-3 were detected by Western blot 20 
analysis. -Tubulin was used as internal control. Quantitative analysis of the 21 
immunoreactivity was performed, and the results are shown in (B and C). Data 22 
represent mean ± SE from at least 3 independent experiments. Statistical analysis was 23 
performed by one-way ANOVA for multiple comparisons, followed by Student 24 
Newman-Keuls as post-hoc test. *p<0.05 compared to corresponding control. 25 
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 1 
Fig. 5 Tg-induced phosphorylation of tau was attenuated by the molecular chaperone 2 
4-PBA. Primary cultures of cortical neurons were co-treated with 4-PBA [1 mM] and 3 
Tg [10 nM] for 6 h. (A) Total cell lysates were collected for the detection of p-tau at 4 
Thr231, Ser262 and Ser396. Representative images of Western blot films were shown. 5 
(B to D) Quantitative analysis of the immunoreactivity was performed, and the results 6 
were shown. Data represent mean ± SE from at least 3 independent experiments. 7 
Statistical analysis was performed by one-way ANOVA for multiple comparisons, 8 
followed by Student Newman-Keuls as post-hoc test. #p<0.05 compared to control. 9 
*p<0.05 compared to cultures treated with Tg [10 nM]. 10 
 11 
Fig. 6 Tg [10 nM] did not trigger an acute elevation of [Ca2+]i. Tg-induced changes in  12 
[Ca2+]i were detected by using Fluo-4AM dye. Cortical neurons were exposed to Tg 13 
[10 nM or 20 M] at time 120 s. The changes of [Ca2+]i were detected and expressed 14 
as fold of control. Data represent mean ± SE from at least 4 independent experiments.  15 
 16 
Fig. 7 Tg did not induce activation of GSK3 but induced the cleavage of p35. 17 
Primary cultures of cortical neurons were incubated with Tg [4 or 10 nM] for different 18 
durations. (A) Total cell lysates were collected for the detection of p-GSK3 (Ser9) 19 
and p-GSK3 (pY216) by Western blot analysis. -Tubulin was used as internal 20 
control. (B and C) Quantitative analysis of the immunoreactivity was performed. Data 21 
represent mean ± SE from at least 3 independent experiments. Statistical analysis was 22 
performed by one-way ANOVA for multiple comparisons, followed by Student 23 
Newman-Keuls as post-hoc test. *p<0.05 compared to corresponding control. 24 
25 
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Table 1 1 
 Primer sequences and reaction conditions for RT-PCR 2 
Target 
genes Sequence 
Product 
size (bp) 
Annealing 
temperature 
(oC) 
No. of 
cycles 
GAPDH F: 5’- gcaagttcaacggcacag-3’ 
R: 5’- gccgtagactccacgacat-3’ 
140 62 33 
Xbp-1 F: 5’-aaacagagtagcagcgcagactgc-3’ 
R: 5’-ggatctctaaaactagaggcttggtg-3’ 
600 62 33 
GADD153 F: 5’-tcagatgaaattgggggcac-3’ 
R: 5’-tttcctcgttgagccgctcg-3’ 
340 60 35 
 3 
4 
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p-Tau (231)
Control
OA [50 nM]
p-eIF2 p-PERK
Supplementary Fig.1 OA-induced hyperphosphorylation of tau led to ER-stress in
primary cultures of hippocampal neurons. OA [50 nM] was added to neuronal cultures
and incubated for 6h to induce tau hyperphosphorylation. The neurons were fixed with
4% paraformaldehyde and stained with specific antibodies against p-Tau (231), p-Tau
(396), Tau 5 and p-PERK. Representative photos of each group are shown,
magnification = 40X. The level of p-Tau (231) was markedly increased in the OA-
treated group. In the same time, the levels of p-eIF2a A and p-PERK were also
increased.
100 M
Supplementary Fig. 2 Ho et. al., 2011
p-Tau (231)
Supplementary Fig.2 Tg induced UPR and phosphorylation of tau in primary cultures
of hippocampal neurons. Tg [10 nM] was added to neuronal cultures and incubated for
6h to induce ER-stress. The neurons were fixed with 4% paraformaldehyde and
stained with specific antibodies against p-Tau (231), p-Tau (396), Tau 5 and p-PERK.
Representative photos of each group are shown, magnification = 40X. The level of p-
PERK, a UPR marker, was elevated in the Tg-treated group. In the same time, the
levels of p-Tau (231), p-Tau (396) were also increased. The level of total tau, which
detected by the Tau 5 antibody remained unchanged.
Control
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p-Tau (396) Tau 5 p-PERK
100 M
Supplementary Fig. 3 Ho et. al., 2011
C   4   10  C   4  10  C   4   10  C   4  10 Tg [nM]
6 h 12 h 18 h 24 h(B)
50 kDa
37 kDa
Total tau (K9JA)
-actin
(A)
- + - + - +
6h 16h 24h
OA [50 nM]
50 kDa
Total tau (K9JA)
-actin
Supplementary Fig.3 Levels of total tau were further confirmed by using the Tau-5
antibody. (A) The pattern of total tau detected by Tau-5 antibody in OA-treated
cultures was similar to those detected by the K9JA pan-tau antibody in Fig. 2A. (B)
The pattern of total tau detected by Tau-5 antibody in Tg-treated cultures was similar
to those detected by the K9JA pan-tau antibody in Fig. 3E.
